From: Biological potential of thiazolidinedione derivatives of synthetic origin
Compounds | Minimum inhibitory concentration (MIC μg/ml) | ||||||
---|---|---|---|---|---|---|---|
S. aureus | E. faecalis | K. pneumonia | E. coli | C. albicans | A. niger | A. flavus | |
64 | 4 | 4 | 250 | 500 | 16 | 16 | 8 |
65 | 4 | 31.25 | 62.5 | 62.5 | 31.5 | 1 | 8 |
66 | 2 | 4 | >Â 500 | >Â 500 | 4 | 8 | 8 |
67 | 1 | 1 | 62.5 | 62.5 | 4 | 4 | 2 |
Ciprofloxacin | 2 | 2 | 1 | 2 | – | – | – |
Norfloxacin | 10 | 3.1 | 0.1 | 10 | – | – | – |
Fluconazole | – | – | – | – | 16 | 8 | 8 |
Griseofulvin | – | – | – | – | 500 | 100 | 7.5 |